Single Shot Fascia Iliaca Block vs Femoral Nerve Block for Analgesia for Surgical Fixation of Hip Fractures

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-08-31

Study Completion Date

2015-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Hip fractures are common in our elderly population and is associated with pain before and after surgery. The current pain management for patients who have undergone surgery for hip fractures include a combination of oral painkillers, opioids (eg morphine) and regional anaesthesia techniques, which involves the injection of local anaesthetic drugs near nerves supplying the hip joint to numb the operation site. As opioids have many side effects, especially in the elderly patients, regional anaesthesia techniques can help to reduce the use of opioids and the related side effects. This may enhance their recovery and length of hospital stay

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Patients With Acute Hip Fractures Will Receive Either the PENG Block or no Block Respectively.

NCT04996979

Hip Fractures

UNKNOWN NA

Adductor Canal Versus Femoral Nerve Block for Analgesia Post Total Knee Arthroscopy

NCT02033603

Knee Osteoarthritis

UNKNOWN NA

Optimization of Analgesia for Hip Fracture Patients

NCT03609645

Hip Fractures

UNKNOWN NA

Blind Fascia Iliaca Compartment Block Compared to Ultrasound-guided Femoral Nerve Block in Patients With Hip Fractures

NCT05365555

Hip Fractures

UNKNOWN

Fascia Iliaca Blocks and Pre-operative Opioid Requirements in Hip Fracture Patients

NCT02804542

Hip Fracture

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hip Fracture

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Femoral nerve block

Procedure: Ultrasound-guided femoral nerve block Drug: Ropivacaine 0.5% 30mls

Group Type ACTIVE_COMPARATOR

Ropivacaine

Intervention Type DRUG

Ultrasound-guided femoral nerve block with Ropivacaine 0.5% 30mls

Fascia Iliaca block

Procedure: Ultrasound-guided suprainguinal approach to fascia iliaca block Drug: Ropivacaine 0.5% 30mls

Group Type ACTIVE_COMPARATOR

Ropivacaine

Intervention Type DRUG

Ultrasound-guided suprainguinal approach to fascia iliaca block with Ropivacaine 0.5% 30mls

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ropivacaine

Ultrasound-guided femoral nerve block with Ropivacaine 0.5% 30mls

Intervention Type DRUG

Ropivacaine

Ultrasound-guided suprainguinal approach to fascia iliaca block with Ropivacaine 0.5% 30mls

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

naropin naropin

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients scheduled for surgical fixation of hip fracture
* Patients with isolated inter-trochantric fracture
* American Society of Anesthesiologists (ASA) physical status 1 to 3
* Patients who are able to give their own consent

Exclusion Criteria

* Patients unable to give consent or inability to communicate/ cooperate
* Patients with regular consumption of strong opioids (morphine, oxycodone) or steroids
* Patients with allergy to local anaesthetics or any drugs included in the study
* Patients with contraindications to spinal anaesthesia such as coagulation disorders/ thrombocytopenia and local infection at site of injection

Eligible Sex

ALL

Accepts Healthy Volunteers

No